Received: 2 November 2020
Accepted: 28 March 2021
First Online: 13 April 2021
: The patient gave informed consent to participate in an ongoing study evaluating the additional value of <sup>18</sup>F-FACBC PET with simultaneous MRI before and after stereotactic radiotherapy. The study was approved by the Regional Ethical Committee (REK, reference number 2018/2243).
: Written informed consent was obtained from the patient for publication of this case report and accompanying images.
: The authors declare that they have no competing interests.